Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction FAST-MI RegistryReportar como inadecuado




Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction FAST-MI Registry - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

* Corresponding author 1 PARCC - Paris-Centre de Recherche Cardiovasculaire 2 GH06-SAT-TNN-TRS-RTH - Unité de Recherche Clinique des Hôpitaux Universitaires Est Parisien 3 LVTS - Laboratoire de Recherche Vasculaire Translationnelle 4 Soins Intensifs et Urgences Cardiologiques 5 Cellules Dendritiques, Immunomodulation et Greffes 6 Soins Intensifs Cardiologiques 7 Cardiologie 8 Cabinet de Cardiologie 9 Service de Cardiologie 10 PMRM - Laboratoire de Protection et Remodelage du Myocarde 11 Unité clinique : maladies coronaires 12 Pôle Cardiologie Interventionnelle - Coro-scanner - IRM Cardiaque

Abstract : IntroductionThere are little data about patients with cardiogenic shock CS who survive the early phase of acute myocardial infarction AMI. The aim of this study was to assess long-term 5-year mortality among early survivors of AMI, according to the presence of CS at the acute stage.MethodsWe analyzed 5-year follow-up data from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction FAST-MI 2005 registry, a nationwide French survey including consecutive patients admitted for ST or non-ST-elevation AMI at the end of 2005 in 223 institutions.ResultsOf 3670 patients enrolled, shock occurred in 224 6.1%, and 3411 survived beyond 30 days or hospital discharge, including 99 2.9% with shock. Early survivors with CS had a more severe clinical profile, more frequent concomitant in-hospital complications, and were less often managed invasively than those without CS.Five-year survival was 59% in patients with, versus 76% in those without shock adjusted hazard ratio HR¿=¿1.72 1.24-2.38, P¿=¿0.001. The excess of death associated with CS, however, was observed only during the first year one-year survival: 77% vs 93%, adjusted HR: 2.87 1.85 to 4.46 P



Autor: Nadia Aissaoui - Etienne Puymirat - Tabassome Simon - Eric Bonnefoy-Cudraz - Denis Angoulvant - Francois Schiele - Hakim Benamer

Fuente: https://hal.archives-ouvertes.fr/



DESCARGAR PDF




Documentos relacionados